QR код

GWAS of CRP response to statins further supports the role of APOE in statin response: A GIST consortium study

Statins are first-line treatments in the primary and secondary prevention of cardiovascular disease. Clinical studies show statins act independently of lipid-lowering mechanisms to decrease C-reactive protein (CRP), an inflammation marker. We aim to elucidate genetic loci associated with CRP statin...

Повний опис

Збережено в:
Автори: Emma F. Magavern, Harshal Deshmukh, Geraldine Asselin, Elizabeth Theusch, Stella Trompet, Xiaohui Li, Raymond Noordam, Y.-D. Ida Chen, Teresa E. Seeman, Kent D. Taylor, Wendy S. Post, Jean-Claude Tardif, Dirk S. Paul, Emelia J. Benjamin, Nancy L. Heard-Costa, Ramachandran S. Vasan, Jerome I. Rotter, Ronald M. Krauss, J.Wouter Jukema, Paul M. Ridker, Patricia B. Munroe, Mark J. Caulfield, Daniel I. Chasman, Marie-Pierre Dubé, Graham A. Hitman, Helen R. Warren
Формат: Artigo
Мова:Inglês
Опубліковано: Elsevier 2025-02-01
Серія:Pharmacological Research
Предмети:
Statins
C-Reactive Protein
Pharmacogenetics
GWAS
Treatment Response
Pharmacology
Онлайн доступ:http://www.sciencedirect.com/science/article/pii/S1043661824005206
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси